|
| |
Trasylol lawsuit | Trasylol attorney | Trasylol lawyer |
| |
Trasylol kidney failure, death, following heart surgery |
| |
1000 deaths a month caused by delay
Thousands of deaths from kidney or renal failure following heart surgery have been linked to Trasylol (aprontinin). On February 17, 2008, 60 minutes reported that according to a renowned researcher 22,000 patients died because the Food and Drug Administration did not remove the heart surgery drug Trasylol two years ago, when his study revealed widespread death associated with it. At a meeting called by the FDA to discuss the safety profile of Trasylol, the drug’s manufacturer, Bayer, failed to tell the FDA about negative results of their own Trasylol study, which also showed that Trasylol was linked to kidney failure, death, heart attack, and stroke. A Canadian study designed to test for kidney failure and death with Trasylol had to be stopped because of severe injury and death to patients.
| |
| |
"We are reviewing cases for individuals who have received an injection prior to heart surgery, and within two weeks of the injection suffered:"
kidney failure
stroke
heart attack
death
|
|
| |
One scientist involved in the early testing of the drug in the 1980’s states that his research showed increased kidney failure in animals given the drug. When he disclosed this to Bayer, however, he says they did not seem interested in looking into it. Critics say that Bayer avoided performing studies that would have proved Trasylol caused kidney failure, heart attack, stroke, and death.
Trasylol (aprotinin) was pulled from the worldwide market in November 2007. Thousands of lives have been lost as a result of this drug. In the last two years alone, as many as 22,000 lives have been lost, and many more have suffered serious injury.
Trasylol health risks: kidney failure, heart attack, stroke, and death
Trasylol FDA Info
Trasylol medical information |
| |
|
|
|
|
|
|
|
| |
|
1.888.604.3438 |
|
|
|
|
|
|
